
Stay-at-home orders during the pandemic forced a shift in patient preferences—and the pharma industry has responded.
Jeremy (“Jerry”) V. Gross is the chief executive officer and co-founder at Vytal, a healthcare technology company. As CEO, Jerry is responsible for overseeing the vision, strategy, and growth of the company as well as its newly launched platform-as-a-service, VytalOS, which offers consumers frictionless prescription management and delivery. Jerry has 30+ years of experience leading development teams and leveraging emerging technologies to create disruptive innovation within biopharma, healthcare, and the financial technology industries.

Published: October 15th 2021 | Updated: